Researchers will investigate the link between persistent organic pollutants in the environment and the development of equine metabolic syndrome.

Researchers will identify the gene(s) and underlying mutations that increase risk of recurrent exertional rhabdomyolysis, or tying up, in Thoroughbred and Standardbred horses.

Researchers will evaluate the safety and effectiveness of a vaccine against foal pneumonia caused by the bacterium Rhodococcus equi.

Researchers will investigate how immune response cells, called dendritic cells, function and the role they play in the development of life-threatening bacterial infections in foals.

Researchers will investigate if macrophages, a type of white blood cell that forms in response to infection or injury, influence the effectiveness of stem cell therapy in horses.

Researchers will evaluate the ability of two agents to improve immune responses against Rhodococcus equi pneumonia in young foals.

Researchers will investigate whether intravenous magnesium sulfate can reverse airway constriction in asthma-like disease of horses.

Researchers will validate genetic mutations that may increase the risk of developing osteochondrosis, a developmental orthopedic disease commonly diagnosed in young horses.

The research fellow will evaluate whether stem cells and regenerative therapies can be used for treating horses with brain and spinal cord diseases.

Researchers will investigate whether novel cancer-causing viruses are found in cats with compromised immune systems.